Save information for later
Sign Up

Learn About Gastrostomy

Who are the top Gastrostomy Local Doctors?
Takeshi Ogura
Elite in Gastrostomy
Elite in Gastrostomy
Osaka, JP 

Takeshi Ogura practices in Osaka, Japan. Mr. Ogura is rated as an Elite expert by MediFind in Gastrostomy. His top areas of expertise are Jaundice, Bile Duct Obstruction, Cholecystitis, Endoscopy, and Stent Placement.

John S. Leeds
Elite in Gastrostomy
Elite in Gastrostomy
Foresterhill Road, 
Aberdeen, SCT, GB 

John Leeds practices in Aberdeen, United Kingdom. Mr. Leeds is rated as an Elite expert by MediFind in Gastrostomy. His top areas of expertise are Exocrine Pancreatic Insufficiency, Bile Acid Malabsorption, Gastrointestinal Bleeding, Gastrostomy, and Endoscopy.

 
 
 
 
Learn about our expert tiers
Learn More
Christopher C. Thompson
Elite in Gastrostomy
Gastroenterology | Hepatology
Elite in Gastrostomy
Gastroenterology | Hepatology

Brigham And Women's Crohn's And Colitis Center

850 Boylston Street, Suite 201 Mass General Brigham Healthcare Center, 
Chestnut Hill, MA 
Languages Spoken:
English

Dr. Christopher C. Thompson is the Director of Endoscopy at Brigham and Women’s Hospital (BWH), Co-director of the Center for Weight Management and Wellness, and Professor of Medicine at Harvard Medical School.  He is also the Advanced Endoscopy Fellowship Program Director and clinical faculty at Boston Children’s Hospital and the Dana-Farber Cancer Institute.  Dr. Thompson’s clinical interests include endoscopic surgery applied to foregut conditions, with a focus on endoscopic treatment of obesity, GERD, Zenker’s diverticula, achalasia, gastroparesis,  postsurgical complications, and pancreatobiliary disease.  He spends the majority of his time performing these advanced endoscopic procedures and also cares for these patients in the ambulatory setting.  The remainder of his time is devoted to research in endoscopic surgery, with a focus on device development, clinical outcomes, and endoscopic education. His research has resulted in numerous patents, development of new endoscopic procedures, and over 300 publications.  He was awarded the Brigham and Women’s Physician Organization Clinical Innovation Award in 2007 for developing and performing the first endoscopic suturing procedure to treat obesity.  He also invented anastomosis technology, which has been shown to treat type 2 diabetes effectively in early clinical trials.  He was responsible for much of the early work in Bariatric Endoscopy, having been called the founding father of the field, and edited the first textbook and video atlas on the subject.  Some of his other important clinical innovations include the development of new endoscopic techniques for treating pancreatic necrosis, gastric outlet obstruction, sleeve gastrectomy stenosis, pancreaticojejunal anastomotic strictures, and postsurgical complications.  He also developed an endoscopic part-task simulator used by many fellowship programs (the TEST box).These accomplishments have led to a broad clinical referral base, and to national and international invitations for lectureships and live case demonstrations, including the American College of Gastroenterology (ACG) Blackwell Lectureship, ACG American Journal of Gastroenterology Lecture, American Gastroenterological Association (AGA) Presidential Plenary Lecture, American Society for Gastrointestinal Endoscopy (ASGE) J Edward Berk Presidential Plenary Lecture, ACG Edgar Achkar Visiting Professorship, all post-graduate education courses for the major US gastroenterology and surgical societies, and numerous respected courses throughout Europe, Asia, and South America.  He has also mentored more than 20 fellows, many of whom have gone on to thrive in prestigious academic institutions, and he established the first Fellowship in Bariatric Endoscopy. Dr. Thompson is rated as an Elite provider by MediFind in Gastrostomy. His top areas of expertise are Obesity, Esophageal Varices, Gastrointestinal Fistula, Endoscopy, and Gastric Bypass.

What are the latest Gastrostomy Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
SJ901: Phase 1/2 Evaluation of Single Agent Mirdametinib (PD-0325901), a Brain-Penetrant MEK1/2 Inhibitor, for the Treatment of Children, Adolescents, and Young Adults With Low-Grade Glioma

Summary: This is an open-label, multi-center, Phase 1/2 study of the brain-penetrant MEK inhibitor, mirdametinib (PD-0325901), in patients with pediatric low-grade glioma (pLGG).